Svelte Medical Systems Overview
- Year Founded
-
2007

- Status
-
Out of Business
- Employees
-
22

- Latest Deal Type
-
Out of Business
Svelte Medical Systems General Information
Description
Developer of drug-eluting coronary stent-on-a-wire Integrated delivery system designed to treat coronary artery disease. The company's device incorporates specialized guide wire tip technology and its proprietary balloon enhances direct stenting and navigates coronary arteries like a guide wire, thereby eliminating the need for additional guide wires and balloons in most cases, enabling patients to experience better clinical outcomes, enhanced comfort and reduced time and cost of procedures.
Contact Information
Website
www.sveltemedical.comCorporate Office
- 675 Central Avenue
- New Providence, NJ 07974
- United States
Corporate Office
- 675 Central Avenue
- New Providence, NJ 07974
- United States
Svelte Medical Systems Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Out of Business | 01-Apr-2023 | Completed | Out of Business | |||
9. Secondary Transaction - Private | 01-Aug-2021 | Completed | Generating Revenue | |||
8. Later Stage VC (Series C) | 23-Apr-2021 | Completed | Generating Revenue | |||
7. Later Stage VC (Series B3) | 21-Jan-2019 | Completed | Generating Revenue | |||
6. Later Stage VC (Series B2) | 21-Nov-2017 | Completed | Generating Revenue | |||
5. Later Stage VC (Series B) | 25-Jul-2016 | Completed | Generating Revenue | |||
4. Later Stage VC | 10-Mar-2014 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 14-Dec-2011 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 07-Dec-2009 | $6M | $20M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 15-May-2009 | $14M | $14M | Completed | Generating Revenue |
Svelte Medical Systems Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B3 | ||||||||
Series B2 | ||||||||
Series B1 | ||||||||
Series A1 | 10,848 | $0.001000 | 8% | $1000 | $1000 | 1x | $1000 | 0.97% |
Series A | 42,296 | $0.001000 | 8% | $1000 | $1000 | 1x | $1000 | 3.77% |
Svelte Medical Systems Comparisons
Industry
Financing
Details
Svelte Medical Systems Competitors (4)
One of Svelte Medical Systems’s 4 competitors is DexCom, a Formerly VC-backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
DexCom | Formerly VC-backed | San Diego, CA | ||||
Baxter International | Corporation | Deerfield, IL | ||||
R3 Vascular | Venture Capital-Backed | Mountain View, CA | ||||
Biotronik | Corporate Backed or Acquired | Berlin, Germany |
Svelte Medical Systems Patents
Svelte Medical Systems Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150238338-A1 | Preventing embolization of drug eluting stents | Active | 15-Dec-2010 | ||
US-9241817-B2 | Preventing embolization of drug eluting stents | Inactive | 15-Dec-2010 | ||
EP-2651346-A2 | A stent delivery catheter | Inactive | 15-Dec-2010 | ||
US-20120158116-A1 | Means and method for preventing embolization of drug eluting stents | Active | 15-Dec-2010 | ||
US-20120150271-A1 | Buddy wire for the coronary arteries | Inactive | 09-Dec-2010 | A61M25/09 |
Svelte Medical Systems Signals
Svelte Medical Systems Investments (1)
Svelte Medical Systems’s most recent deal was a Early Stage VC with Ostial Solutions for . The deal was made on 08-Sep-2010.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Ostial Solutions | 08-Sep-2010 | Early Stage VC | Therapeutic Devices |
Svelte Medical Systems FAQs
-
When was Svelte Medical Systems founded?
Svelte Medical Systems was founded in 2007.
-
Where is Svelte Medical Systems headquartered?
Svelte Medical Systems is headquartered in New Providence, NJ.
-
What is the size of Svelte Medical Systems?
Svelte Medical Systems has 22 total employees.
-
What industry is Svelte Medical Systems in?
Svelte Medical Systems’s primary industry is Therapeutic Devices.
-
Is Svelte Medical Systems a private or public company?
Svelte Medical Systems is a Private company.
-
What is Svelte Medical Systems’s current revenue?
The current revenue for Svelte Medical Systems is
. -
How much funding has Svelte Medical Systems raised over time?
Svelte Medical Systems has raised $172M.
-
Who are Svelte Medical Systems’s competitors?
DexCom, Baxter International, R3 Vascular, and Biotronik are competitors of Svelte Medical Systems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »